Modelling Autistic Neurons with Induced Pluripotent Stem Cells
Annie Kathuria1,2, Carlo Sala3, Chiara Verpelli4
1Centre for Stem Cells and Regenerative Medicine, King's College, London, UK.
Insights
Autism spectrum disorder (ASD) research uses induced pluripotent stem cells (iPSCs) to model neurodevelopmental conditions. This review explores iPSC models for understanding ASD heterogeneity and co-occurring diseases.
Area of Science:
- Neuroscience
- Developmental Biology
- Genetics
Background:
- Autism spectrum disorder (ASD) is a complex neurodevelopmental condition affecting over 1% of children, characterized by social-communication deficits and restricted behaviors.
- Current treatment limitations stem from clinical/genetic heterogeneity and poorly understood pathophysiological mechanisms.
- Induced pluripotent stem cells (iPSCs), derived from adult cells, offer a powerful tool for studying human cellular phenotypes.
Purpose of the Study:
- To systematically review the application of human iPSCs in modeling various autism spectrum disorder (ASD) variants.
- To explore how iPSC-derived models contribute to understanding the cellular and molecular underpinnings of ASD.
- To examine the use of iPSCs in modeling diseases co-occurring with ASD.
Main Methods:
- Systematic literature review of studies utilizing human induced pluripotent stem cells (iPSCs) for autism spectrum disorder (ASD) modeling.
- Analysis of research focusing on cellular and molecular phenotypes derived from iPSC lines of individuals with ASD.
- Inclusion of studies investigating ASD-associated genetic variants and co-morbid conditions within iPSC models.
Main Results:
- Human iPSCs enable the recapitulation of specific cellular and molecular phenotypes relevant to ASD.
- iPSC-based models facilitate the investigation of genetic heterogeneity and its impact on ASD pathology.
- The use of iPSCs aids in studying complex interactions between ASD and co-morbid conditions at a cellular level.
Conclusions:
- Human iPSCs provide a valuable platform for dissecting the complex pathophysiology of autism spectrum disorder (ASD).
- iPSC technology is crucial for advancing research into ASD variants and associated co-morbidities.
- Further utilization of iPSC models promises to uncover novel therapeutic targets for ASD.
Abstract:
Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects more than 1% of children per current estimates. It has been characterised by the following two core behavioural phenotypes: (1) deficits in social interaction and communication and (2) repetitive behaviours, restricted interests and activities. Due to the complex nature of ASD, there are currently no effective treatments. The reason behind this is the clinical and genetic heterogeneity between affected individuals on the one hand and the lack of understanding of the underpinning pathophysiological mechanisms on the other hand. Induced pluripotent stem cells (iPSCs) are reprogrammed stem cells from adult cells. These have the capacity to self-renew and differentiate into any type of cells in the body. Therefore, human iPSCs provide a unique opportunity to study the human cellular and molecular phenotypes associated with ASD. Here, we systematically review various ASD variants and co-morbid diseases modelled using human iPSCs.
More Related Videos
10:53Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
07:33Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors
Published on: May 1, 2019
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
iPS Cell Differentiation
